(Q33183441)

23 July 2017

title

A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis (English)

1 reference

23 July 2017

0 references

Maria B Arvelo

1

1 reference

23 July 2017

Jeffrey T Cooper

2

1 reference

23 July 2017

Christopher Longo

3

1 reference

23 July 2017

Soizic Daniel

4

1 reference

23 July 2017

Shane T Grey

5

1 reference

23 July 2017

Jerome Mahiou

6

1 reference

23 July 2017

Eva Czismadia

7

1 reference

23 July 2017

Graziella Abu-Jawdeh

8

1 reference

23 July 2017

Christiane Ferran

9

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

23 July 2017

1 reference

23 July 2017

volume

35

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

535-543

1 reference

Intrahepatic T cells in hepatitis B: viral control versus liver cell injury

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Galactosamine-induced sensitization to the lethal effects of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Animal models of acute hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Overexpression of A20 in endothelial cells of vascularized grafts creates a protective barrier against TNF- and FAS-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Protective genes expressed in endothelial cells: a regulatory response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Assessment of recombinant adenoviral vectors for hepatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.31309

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.31309

1 reference

23 July 2017

1 reference